List of works - Elizabeth Dudnik

ALK-Rearranged Non-Small-Cell Lung Cancer Is Associated With a High Rate of Venous Thromboembolism

scientific article published on 26 October 2016

Alternative nivolumab duration and scheduling in advanced non-small cell lung cancer (aNSCLC): a real-world evidence

scientific article published on 01 September 2020

BRAF Mutant Lung Cancer: Programmed Death Ligand 1 Expression, Tumor Mutational Burden, Microsatellite Instability Status, and Response to Immune Check-Point Inhibitors

scientific article published on 30 April 2018

Biomarker-Driven Therapy in Metastatic Gastric and Esophageal Cancer: Real-Life Clinical Experience

scientific article published on 20 January 2018

Clinical Impact of Hybrid Capture-Based Next-Generation Sequencing on Changes in Treatment Decisions in Lung Cancer

scientific article published on 9 November 2016

Clinical activity of brigatinib in ROS1-rearranged non-small cell lung cancer

scientific article published on 27 May 2020

Durable brain response with pulse-dose crizotinib and ceritinib in ALK-positive non-small cell lung cancer compared with brain radiotherapy.

scientific article published on 8 December 2015

Effectiveness and safety of nivolumab in advanced non-small cell lung cancer: The real-life data

scientific article

Intensity-modulated radiotherapy is a safe and effective treatment for localized malignant pleural mesothelioma

scientific article published on 21 September 2018

Intracranial response to nivolumab in NSCLC patients with untreated or progressing CNS metastases.

scientific article published on 31 May 2016

Mistletoe as complementary treatment in patients with advanced non-small-cell lung cancer treated with carboplatin-based combinations: A randomised phase II study ⬇️

scientific article published on December 5, 2012

Not only for melanoma. Subcutaneous pseudoprogression in lung squamous-cell carcinoma treated with nivolumab: A case report

scientific article published on January 2017

Osimertinib in advanced EGFR-mutant lung adenocarcinoma with asymptomatic brain metastases: an open-label, 3-arm, phase II pilot study

scientific article published on 27 December 2021

RET Fusion Lung Carcinoma: Response to Therapy and Clinical Features in a Case Series of 14 Patients.